FindTrial
Sign In

The retrospective study on the intervention of traditional Chinese medicine in mild and asymptomatic infectors with COVID-19 in real world

The retrospective study on the intervention of traditional Chinese medicine in mild and asymptomatic infectors with COVID-19 in real world

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200063151
Enrollment
Unknown
Registered
2022-08-31
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Observation group:Taking traditional Chinese Medicine (standardized)
Control group:None

Sponsors

Longhua Hospital, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 120 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 2 years. 2. Asymptomatic patients and mild confirmed cases of COVID-19.

Exclusion criteria

Exclusion criteria: 1. Participating in other clinical trials within the past 3 months or currently. 2. Patients of severe illness or death within 48 hours. 3. Severe mental illness. 4. Pregnant patients or breastfeeding patients.

Design outcomes

Primary

MeasureTime frame
nucleic acid conversion time;—

Secondary

MeasureTime frame
hospitalization days;diarrhea;vomit;—

Countries

China

Contacts

Public ContactTian Yu

Longhua Hospital, Shanghai University of Traditional Chinese Medicine

tyrain2000@sina.com+86 13795491542

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026